UA
36
3
WY
56
2
BAC
80
3
VTR
69
2
FSLR
78
5
HSY
51
8
OMC
66
-3
FITB
78
3
PX
53
3
CME
52
7
DLTR
58
-5
MTB
75
2
PNR
54
3
DHI
37
-3
ROP
42
4
STI
21
3
HIG
70
2
CMI
75
4
GT
39
-3
CVS
40
3
UA
36
3
WY
56
2
BAC
80
3
VTR
69
2
FSLR
78
5
HSY
51
8
OMC
66
-3
FITB
78
3
PX
53
3
CME
52
7
DLTR
58
-5
MTB
75
2
PNR
54
3
DHI
37
-3
ROP
42
4
STI
21
3
HIG
70
2
CMI
75
4
GT
39
-3
CVS
40
3
Financhill
Back

Eton Pharmaceuticals, Inc. 10K Form

Buy
58

ETON
Eton Pharmaceuticals, Inc.

Last Price:
$16.56
Seasonality Move:
-2.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ETON News And Ratings

See the #1 stock for the next 7 days that we like better than ETON

ETON Financial Statistics

Sales & Book Value

Annual Sales: $39M
Cash Flow: $11.7M
Price / Cash Flow: 34.31
Annual Sales: $0.86
Price / Book: 19.21

Profitability

EPS (TTM): -0.24910
Net Income (TTM): $-6.7M
Gross Margin: $23.4M
Return on Equity: -29.85%
Return on Assets: -8.31%

Eton Pharmaceuticals, Inc. Earnings Forecast

Key Eton Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 8 years for ETON is 60.01%.
  • The Selling, General & Administrative Expenses for ETON have been equal to 58.32% of Gross Profit Margin.
  • The Research & Development expenses have been 8.34% of Revenue.
  • The Net Earning history of ETON is -9.80% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

Eton Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ETON
CUSIP: 29772L
Website: etonpharma.com

Debt

Debt-to-Equity Ratio: 1.34
Current Ratio: 1.63
Quick Ratio: 1.14

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 16.41

ETON Technical Analysis vs Fundamental Analysis

Buy
58
Eton Pharmaceuticals, Inc. (ETON) is a Buy

Is Eton Pharmaceuticals, Inc. a Buy or a Sell?